1,184
Views
0
CrossRef citations to date
0
Altmetric
Editorial

The changing face of virology: will the application of molecular techniques inevitably lead to new and better vaccines?

Pages 663-666 | Published online: 10 Jan 2014

References

  • Tannock GA. What hope for recombinant vaccines? Today's Lifi Science 3,12–15 (1991).
  • Heymann DL. Polio eradication: finishing the job and protecting the investment. BulL World Health Organ. 82(1), 1-1A ISSN 0042–9686 (2004).
  • Doherty PC. Update: the numbers game for virus-specific CD8+ T-cells. Science 280,227 (1998).
  • Marra MA, Jones SJM, Astell CR, et al. The genome sequence of the SARS-associated coronavirus. Science 300,1399–1404 (2003).
  • Haynes B, Pantaleo G, Fauci A. Towards an understanding of the correlates of protective immunity to HIV infection. Science 271, 324–328 (1996).
  • Cohen OJ, Fauci AS Knipe DM. Pathogenesis and medical aspects of HIV-1 infection. In: Fields Virology 2,Fourth Edition. , Howley PM (Eds). Lippincott, Williams and Wilkins, PA, USA, 2043–2094 (2001).
  • Major ME, Feinstone SM. Characteristics of hepatitis C infectious clones in chimpanzees: long-term studies. Curr. Top. Microbial. Immunol. 242,279–298 (2000).
  • Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine — USA, 1998-1999. Morb. Mort. Wkly Rep. 48, 577–581 (1999).
  • Bharadwaj M, Moss DJ. Epstein—Barr virus vaccine: a cytotoxic T-cell-based approach. Expert Rev. Vaccines 1(4), 467–472 (2002).
  • Halstead SB. Antibody, macrophages, dengue virus infection, shock and hemorrhage; a pathogenetic cascade. Rev. Infect. Dis. 11, S830—S839 (1989).
  • Guirakhoo F, Pugachev K, Zhang Z, et al. Safety and efficacy of chimeric yellow fever—dengue virus tetravalent vaccine formulations in nonhuman primates. J. Virol. 78,4761–4775 (2004).
  • Lai CJ, Monath TP. Chimeric flavivirus novel vaccines against dengue fever, tick-borne encephalitis and Japanese encephalitis. Adv. Virus Res. 61,469–509 (2003).
  • Anonymous. St Jude develops vaccine against potential pandemic H5N1 using reverse genetics. Vaccine Wkly 22 (2003).
  • Wright PF, Karron RA, Belshe RB, et al. Evaluation of a cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J. Infict. Dis. 182, 1331–1342 (2000).
  • Frazer IH. Prevention of cervical cancer through papillomavirus vaccination. Nature Rev. Immund 4,46–54 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.